Summary of Drugs for ADHD for Dental Practice
This summary outlines the pharmacological agents used to treat ADHD, with a specific focus on their side effects and key implications for dental practice.
Pharmacological Treatment
The primary pharmacological treatment for ADHD involves psychostimulants. Other non-stimulant drugs, such as atomoxetine and guanfacine, are also used.
Drug Classes and Their Dental Implications
Psychostimulants
-
Examples: Dexamfetamine, Lisdexamfetamine (Vyvanse), Methylphenidate (Concerta).
-
Adverse Effects: Psychostimulants as a class can cause dry mouth, anxiety, irritability, headache, dizziness, aggression, and palpitations. Infrequently, they may cause movement disorders or tics.
-
Dental Implications: The document notes that there are no significant dental drug interactions for this class of medication. The main concern for dental practitioners is the high prevalence of dry mouth, which increases caries risk.
Atomoxetine
-
Adverse Effects: Atomoxetine can cause dry mouth, dizziness, irritability, aggression, and temper tantrums. Infrequent side effects include palpitations and orthostatic hypotension.
-
Dental Implications: Similar to psychostimulants, the document notes no significant dental drug interactions for atomoxetine. Management focuses on the oral health consequences of dry mouth.
Guanfacine
-
Example: Guanfacine (Intuniv).
-
Adverse Effects: Guanfacine is associated with drowsiness, dizziness, dry mouth, headache, hypotension, fatigue, and sedation. Fainting is an infrequent side effect.
-
Dental Implications:
-
Drug Interactions: Unlike the other ADHD drugs, guanfacine has significant interactions. Its sedative effects are additive with other CNS depressants, and its metabolism can be affected by CYP3A4 inhibitors.
-
Side Effects: The sedative properties and risk of hypotension require care when managing the patient in the dental chair.
-
Overall Dental Management Summary
-
Dry Mouth: This is the most consistent and important dental side effect across all three classes of ADHD medication (psychostimulants, atomoxetine, and guanfacine), necessitating a strong focus on caries prevention through oral hygiene education, regular recalls, and fluoride treatments.
-
Behavioral and Sedative Effects: Behavioral side effects from psychostimulants and atomoxetine (e.g., anxiety, irritability) may affect patient cooperation. In contrast, the sedative effects of guanfacine may cause drowsiness during appointments.
-
Drug Interactions: While psychostimulants and atomoxetine have no major dental interactions listed, clinicians must be aware of the interactions between guanfacine and other CNS depressants or CYP3A4 inhibitors.